Capricor therapeutics, inc. (CAPR)
Income statement / Yearly
Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10
REVENUE
Collaboration income

-

-

-

3,190

3,776

4,166

0

-

1,354

-

Revenue

1,005

1,671

2,666

-

-

-

-

-

-

-

Grant income

-

-

-

808

1,741

620

503

1,898

0

-

Other income

-

-

-

0

-

-

-

-

-

-

TOTAL REVENUE

1,005

1,671

2,666

3,998

5,517

4,786

503

-

1,354

-

OPERATING EXPENSES
Research and development

5,141

12,066

10,766

16,042

13,757

7,787

5,197

2,634

4,136

4,080

General and administrative

3,597

4,931

4,762

4,933

4,372

3,017

2,208

1,364

2,116

2,212

TOTAL OPERATING EXPENSES

8,738

16,998

15,528

20,975

18,129

10,804

7,406

3,998

6,253

6,293

LOSS FROM OPERATIONS

-7,733

-15,327

-12,862

-16,976

-12,611

-6,017

-6,902

-2,100

-4,899

-6,293

OTHER INCOME (EXPENSE)
Investment income

94

135

38

14

3

1

-11

28

-

-

Loss on disposal of fixed asset

-2

0

-

-

-

-

-

-

-

-

Interest income

-

-

-

-

-

-

-

-

6

20

Interest expense

-

-

398

344

248

200

58

0

0

-

Forgiveness of loan payable

-

-

15,654

0

-

-

-

-

-

-

Impairment of in-process research and development

-

-

-

1,500

0

-

-

-

-

-

Impairment of goodwill

-

-

-

-

-

-

1,919

0

-

-

Other income (expense)

-

-

-

-

-

-

-

-

8

241

TOTAL OTHER INCOME (EXPENSE)

92

135

15,293

-1,830

-245

-198

-1,989

28

14

262

NET LOSS

-7,641

-15,191

2,431

-18,806

-12,857

-6,216

-8,891

-2,071

-4,884

-6,031

OTHER COMPREHENSIVE INCOME (LOSS)
Net unrealized gain (loss) on marketable securities

-13

0

8

-5

9

0

20

-21

-

-

COMPREHENSIVE LOSS

-7,654

-15,190

2,439

-18,812

-12,847

-6,215

-8,871

-

-

-

COMPREHENSIVE LOSS

-

-

-

-

-

-

-

-2,093

-

-

Net loss per share, basic and diluted

-2.06

-5.17

0.10

-

-0.81

-0.53

-0.85

-0.21

-0.13

-0.19

Weighted average number of shares, basic and diluted

3,711

2,941

23,193

-

15,902

11,696

10,501

9,945

37,328

-

Net income (loss) per share - basic (in dollars per share)

-

-

-

-1.01

-

-

-

-

-

-

Weighted average number of shares - basic (in shares)

-

-

-

18,551

-

-

-

-

-

-

Net income (loss) per share - diluted

-

-

0.09

-1.01

-

-

-

-

-

-

Weighted average number of shares - diluted

-

-

26,788

18,551

-

-

-

-

-

-

Weighted-average common shares outstanding

-

-

-

-

-

-

-

-

-

32,168